drugset / Trial / NCT03062839

Melatonin as Adjuvant Treatment for ADHD in Adults

NCT03062839

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study aims to evaluate the effect of melatonin supplementation as adjuvant treatment in ADHD in adults.

Timeline

Start
2017-09-01
Primary completion
2019-02-28
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 5 mg